Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Korro Bio (KRRO) is now available.
Steve Colletti, Ph.D., has announced his resignation as Chief Scientific Officer from Korro Bio, Inc., which will become effective on August 2, 2024. His departure marks a significant change in the company’s leadership team, potentially impacting investors and stakeholders tracking the biotech firm’s progress.
Learn more about KRRO stock on TipRanks’ Stock Analysis page.